PL2802345T3 - Szczepionka mtb-c przeciw reakcjom alergicznym - Google Patents

Szczepionka mtb-c przeciw reakcjom alergicznym

Info

Publication number
PL2802345T3
PL2802345T3 PL12709369T PL12709369T PL2802345T3 PL 2802345 T3 PL2802345 T3 PL 2802345T3 PL 12709369 T PL12709369 T PL 12709369T PL 12709369 T PL12709369 T PL 12709369T PL 2802345 T3 PL2802345 T3 PL 2802345T3
Authority
PL
Poland
Prior art keywords
mtb
vaccine against
allergic responses
against allergic
responses
Prior art date
Application number
PL12709369T
Other languages
English (en)
Inventor
Pere Joan Cardona Iglesias
Isabel Amat Riera
Blanca REYES MORENO
Maria Mercè AMAT FABREGAT
Original Assignee
Archivel Farma, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archivel Farma, S.L. filed Critical Archivel Farma, S.L.
Publication of PL2802345T3 publication Critical patent/PL2802345T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12709369T 2012-01-12 2012-01-12 Szczepionka mtb-c przeciw reakcjom alergicznym PL2802345T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12709369.8A EP2802345B1 (en) 2012-01-12 2012-01-12 Mtb-c vaccine against allergic responses
PCT/IB2012/000353 WO2013104943A1 (en) 2012-01-12 2012-01-12 Mtb-c vaccine against asthma

Publications (1)

Publication Number Publication Date
PL2802345T3 true PL2802345T3 (pl) 2018-08-31

Family

ID=45852617

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12709369T PL2802345T3 (pl) 2012-01-12 2012-01-12 Szczepionka mtb-c przeciw reakcjom alergicznym

Country Status (15)

Country Link
US (1) US9682042B2 (pl)
EP (1) EP2802345B1 (pl)
CN (1) CN104411326B (pl)
AU (1) AU2012365465B2 (pl)
BR (1) BR112014017217B1 (pl)
CA (1) CA2861074C (pl)
DK (1) DK2802345T3 (pl)
ES (1) ES2670493T3 (pl)
IN (1) IN2014MN01594A (pl)
NO (1) NO2802345T3 (pl)
PL (1) PL2802345T3 (pl)
PT (1) PT2802345T (pl)
RU (1) RU2602771C2 (pl)
WO (1) WO2013104943A1 (pl)
ZA (1) ZA201405107B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103720657B (zh) * 2013-11-19 2017-01-04 广东丸美生物技术股份有限公司 一种可变形脂质体的制备方法,及其制备的可变性脂质体
RU2652752C1 (ru) * 2017-06-15 2018-04-28 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" Способ лечения бронхиальной астмы
EP3797791A1 (en) * 2019-09-26 2021-03-31 Universidad De Zaragoza Therapeutic efficacy by pulmonary delivery of live attenuated mycobacteria

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU720288B2 (en) 1995-02-22 2000-05-25 Adcock Ingram Limited A method for the isolation and purification of lipid cell-wall components
GB9813100D0 (en) 1998-06-18 1998-08-19 Secr Defence Method of forming liposomes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
BR0103887C1 (pt) 2001-07-17 2005-11-08 Univ Minas Gerais Composições imunogênicas contendo microesferas biodegradáveis encapsulando antìgenos, vetores gênicos e adjuvantes
ES2231037B1 (es) 2003-10-31 2005-12-16 Archivel Technologies, Sl Agente inmunoterapico util para el tratamiento combinado de la tuberculosis en asociacion con otros farmacos.
EP1761662A4 (en) 2004-07-01 2010-02-03 Univ California PROTEOMICS WITH HIGH THROUGHPUT
SI2457926T1 (sl) 2005-04-29 2015-01-30 Glaxosmithkline Biologicals S.A. Nov postopek za preprečevanje ali zdravljenje infekcije z M. tuberculosis
WO2007022152A2 (en) 2005-08-15 2007-02-22 The Research Foundation Of State University Of New York Lipid nano particulates containing antigens as cancer vaccines
WO2008051245A2 (en) 2005-12-02 2008-05-02 Novartis Ag Nanoparticles for use in immunogenic compositions
TW200806317A (en) 2006-03-20 2008-02-01 Wyeth Corp Methods for reducing protein aggregation
US20090081284A1 (en) * 2006-04-20 2009-03-26 Tokai University Educational System Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
EP2076244B1 (en) 2006-10-10 2016-12-07 Jina Pharmaceuticals Inc. Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
ES2307402B1 (es) 2006-10-30 2009-09-30 Archivel Farma, S.L. Vacuna profilactica contra la tuberculosis.
US8741313B2 (en) 2008-01-11 2014-06-03 Emory University Polypeptide vaccine and vaccination strategy against mycobacterium
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
KR20170072366A (ko) 2009-04-24 2017-06-26 스태튼스 세룸 인스티튜트 재활성화를 예방하기 위한 결핵 백신
DK2651436T3 (da) 2010-12-14 2016-06-20 Glaxosmithkline Biologicals Sa Mycobakterie antigen sammensætning.

Also Published As

Publication number Publication date
ZA201405107B (en) 2020-11-25
CN104411326B (zh) 2018-02-02
RU2014133042A (ru) 2016-02-27
AU2012365465B2 (en) 2017-05-18
ES2670493T3 (es) 2018-05-30
IN2014MN01594A (pl) 2015-05-08
DK2802345T3 (en) 2018-04-30
US9682042B2 (en) 2017-06-20
US20150132364A1 (en) 2015-05-14
EP2802345A1 (en) 2014-11-19
AU2012365465A1 (en) 2014-08-21
EP2802345B1 (en) 2018-03-07
CA2861074A1 (en) 2013-07-18
NO2802345T3 (pl) 2018-08-04
RU2602771C2 (ru) 2016-11-20
CN104411326A (zh) 2015-03-11
BR112014017217A2 (pt) 2017-06-13
BR112014017217A8 (pt) 2017-07-04
BR112014017217B1 (pt) 2023-01-17
PT2802345T (pt) 2018-04-24
CA2861074C (en) 2018-11-06
WO2013104943A1 (en) 2013-07-18

Similar Documents

Publication Publication Date Title
IL235890A0 (en) vaccine
DE112013000343A5 (de) Grill
ZA201406400B (en) Eye massage device
GB201218427D0 (en) Blender
ZA201502336B (en) Enzalutamide polymorphic forms and its preparation
EP2827759A4 (en) FUNDUS CAMERA
DK2834924T3 (da) MIMO-konfigurationsfremgangsmåder og -indretning
GB201223386D0 (en) Vaccine
SG11201406871UA (en) Benzamide derivative
GB201420527D0 (en) Electrical-wire-protecting member
EP2930055A4 (en) HEADREST
IL234604A (en) Carbon-glycophide vaccines are vaccinated
GB201711697D0 (en) Blender
PL2914085T3 (pl) Urządzenie koszące
BR112015007217A2 (pt) compostos e usos do composto
EP2939875A4 (en) HEADREST
GB2518076B (en) Electrical-wire-protecting member
PT2802345T (pt) Vacina mtb-c contra a asma
HRP20190033T1 (hr) Pripravak
GB201210226D0 (en) Vaccine
GB201202090D0 (en) Vaccine
DK2846829T3 (en) Vaccine combinations
GB201220061D0 (en) Four eyes
GB201217321D0 (en) Vaccine
GB201206169D0 (en) Vaccine